- Avian influenza vaccines are crucial in controlling and preventing outbreaks of avian flu, which can significantly affect poultry populations and human health. These vaccines are designed to protect poultry from various strains of the virus, including H5, H7, and H9.
- The demand for these vaccines is primarily driven by the increased incidence of avian influenza outbreaks and the growing need for biosecurity in poultry farming to protect both animal and public health.
- The Asia-Pacific region is expected to dominate the avian influenza vaccines market due to its large poultry farming industry and frequent outbreaks of avian influenza.
- North America and Europe are expected to witness moderate growth, with an increasing focus on vaccination programs to control the spread of avian influenza and prevent economic losses in the poultry industry.
- The H5 strain vaccine segment is expected to hold the largest market share, accounting for 46.9% of the total market, due to the frequent outbreaks of this strain in poultry farms. This leads to increased vaccination demand, as controlling H5 avian influenza is critical for maintaining poultry health and preventing widespread outbreaks.
